Assets Lave om Dato
AbbVie USD 136.22B 854M 2023-09
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Amgen USD 97.15B 6.62B 2023-12
Astellas Pharma JPY 3.54T 745.06B 2023-09
Bayer EUR 117.24B 4.43B 2023-09
Biogen USD 26.84B 1.35B 2023-12
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Bristol-Myers Squibb USD 91.26B 2.23B 2023-09
Celldex Therapeutics USD 465.63M 185.37M 2023-12
Daiichi Sankyo JPY 2.65T 33.03B 2023-09
Eisai JPY 1.33T 28.9B 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Exelixis USD 2.98B 165.56M 2023-09
Genmab DKK 35.24B 3.26B 2023-09
Gilead Sciences USD 62.13B 248M 2023-12
GlaxoSmithKline GBP 60.86B 1.4B 2023-09
Incyte USD 6.78B 393.87M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Merck USD 106.73B 2.26B 2023-09
Moderna USD 18.43B 1.02B 2023-12
Nektar Therapeutics USD 442.24M 52.04M 2023-09
Pfizer USD 215.02B 5.15B 2023-09
Regeneron Pharmaceuticals USD 33.08B 916.9M 2023-12
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Takeda JPY 14.87T 79.15B 2023-09
Teva Pharmaceutical Industries USD 42.09B 1.01B 2023-09
Vertex Pharmaceuticals USD 21.73B 1.38B 2023-09
Xencor USD 952.69M 174.26M 2023-12



Seattle Genetics Aktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2024.